High Multiplexing Liquid Array Assay Platform

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$99,999.00
Award Year:
2009
Program:
SBIR
Phase:
Phase I
Contract:
1R43EB008616-01A1
Agency Tracking Number:
EB008616
Solicitation Year:
2009
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2009-2
Small Business Information
ARRAYOMICS, INC.
ARRAYOMICS, INC., 9909 HIBERT ST, STE A, SAN DIEGO, CA, 92131
Hubzone Owned:
Y
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
140695847
Principal Investigator:
DAVID ROTHWARF
(858) 245-2435
DROTHWARF@ARRAYOMICS.COM
Business Contact:
CHRISTOPHER HEROLD
(858) 578-0977
drothwarf@arrayomics.com
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): The aim of this project is to expand the capabilities of a novel liquid array' platform, based on Encoded Sortable Particle (ESP) technology to make it cost and performance compatible with high multiplex assays. ESPs are optically-encoded microfabricated particles that can be manipulated using magnetic force. We will adapt our ESP-based liquid array system, which has already been successfully applied in the low multiplex space, to accommodate assays of 100,000-plex or more. ESP technology has broad applicability and should be a valuable tool in the diagnosis, prognosis, and characterization of a variety of disease states, including cancer, heart disease, arthritis and inflammatory diseases, kidney disease, liver disease, allergic responses, and infectious diseases (e.g. HIV). PUBLIC HEALTH RELEVANCE: ESP technology as applied to the high multiplex assay space will provide a broad platform for many different kinds of assays. The ESP platform is intrinsically versatile, and has the potential to be used in basic biomedical research, as well as high- throughput discovery and clinical diagnostics. The ability to control the particles magnetically (in a manner significantly different from magnetic beads) is a significant advantage. This technology should be useful in the diagnosis and prognosis of a variety of disease states, including cancer, heart disease, arthritis and inflammatory diseases, kidney disease, and infectious diseases (e.g. HIV).

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government